Burning Rock Biotech
BNR
16 hedge funds and large institutions have $27.4M invested in Burning Rock Biotech in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 16 → 16 (0)
0% more ownership
Funds ownership: 18.93% → 18.93% (+0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
22% less capital invested
Capital invested by funds: $34.9M → $27.4M (-$7.58M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$6.09M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$463K |
| 3 |
Renaissance Technologies
New York
|
+$112K |
| 4 |
Morgan Stanley
New York
|
+$89.9K |
| 5 |
JP Morgan Chase
New York
|
+$4.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CRCM LP
San Francisco,
California
|
-$5.48M |
| 2 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$628K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$220K |
| 4 |
RWMG
Redwood Wealth Management Group
Medford,
New Jersey
|
-$45.7K |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
-$43.7K |
BNR Hedge Fund Activity: Q1 2026 in Review
16 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q1 2026, worth a combined $27.4M — down 22% from $34.9M a quarter earlier.
Fund positioning in BNR was balanced in Q1 2026: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 7 trimmed.
The largest buyer was Kynam Capital Management, adding an estimated $6.09M. The largest seller was CRCM LP, cutting an estimated $5.48M.
- 16 institutional investors held Burning Rock Biotech (BNR) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $27.4M of Burning Rock Biotech stock for Q1 2026, down 22% quarter-over-quarter.
- 3 funds opened new Burning Rock Biotech positions in Q1 2026 and 3 closed out, a net change of 0 holders.
- The largest Burning Rock Biotech buyer in Q1 2026 was Kynam Capital Management, an estimated $6.09M added.
- The largest Burning Rock Biotech seller in Q1 2026 was CRCM LP, an estimated $5.48M sold.
Based on aggregated 13F filings for Q1 2026.